In this regard, it plans to start an early-stage study with a new candidate, ALLO-329, in lupus/systemic lupus erythematosus (SLE) indication in mid-2025 and expects to have proof-of-concept by ...

Leerink Global Healthcare Conference 2025 March 10, 2025 11:20 AM ETCompany ParticipantsAlisha Alaimo - President of ...

Additionally, GRI Bio is working on a pipeline of diverse NKT cell agonists for systemic lupus erythematosus and possesses over 500 proprietary compounds to support its research. The release also ...

Good day, and thank you for standing by. Welcome to the Nektar Therapeutics Fourth Quarter 2024 financial results conference call. At this time, all participants are in a listen-only mode. After ...

CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 -- -- Advancing four clinical programs for hematologic malignancies and autoimmune diseases -- -- $249.4 ...

GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T ("NKT") cell modulators ...

A look at the curved oval iconic representation of Shiva Lingam placed on a globular base which is found in the Sanctum Sanctorum Garbhagraha of all Shiva temples has given rise to diverse explanation ...

Dr Pandey noted that autoimmune diseases like rheumatoid arthritis, lupus, and psoriatic arthritis are increasingly affecting women, particularly those of reproductive age. These diseases often ...

Important note: Hazardous substance assessments are technical documents produced by Health Canada as educational and informational resources for suppliers of hazardous products under the Hazardous ...

Introduction: Systemic lupus erythematosus (SLE) is characterized by dysregulated humoral immunity, leading to the generation of autoreactive B cells that can differentiate both within and outside of ...